GLOSSARY

Caffeine-Induced Jitters describes unwanted caffeine-related symptoms, including restlessness or jitteriness, interpreted with total exposure and sensitivity.

Caffeine antagonizes adenosine receptors and can improve selected endurance, alertness and high-intensity outcomes. Response varies with dose, task and individual sensitivity. More caffeine is not necessarily more effective, and side effects can outweigh a modest performance benefit. Count caffeine from coffee, gels, drinks, tablets and combinations together. Sleep disruption, anxiety, gastrointestinal symptoms and cardiovascular complaints deserve attention. Pure concentrated caffeine powders pose a particular dosing hazard; a product's stimulant effect is not proof of adequate or safe fueling.

Caffeine delivery and clearance vary with formulation, food, metabolism, medication and individual physiology. Chewing gum and swallowed products can have different absorption patterns, while the amount in coffee can vary. CYP1A2 contributes importantly to metabolism, producing metabolites including paraxanthine. Habitual intake and withdrawal can influence study interpretation, but complete abstinence is not a universal requirement for benefit. A single genotype does not reliably determine every performance response. Consider both the intended session and the possibility of residual effects on later sleep.

For example, add the caffeine from coffee, a gel and a pre-workout product before evaluating the day's exposure. An athlete may feel more alert yet sleep poorly afterward. Judge the strategy by the intended performance task and subsequent recovery, and avoid treating the strongest sensation or largest dose as the best outcome.

The dose refers to the amount of the relevant active ingredient, not necessarily the mass of powder or the number of scoops. A single dose, daily total and body-mass-relative dose describe different quantities. Larger amounts can increase adverse effects without improving performance. Loading, maintenance and acute timing are ingredient-specific strategies rather than universal rules. Check all products used together so that repeated ingredients do not create an unintended total intake.

Apparent individual responses combine biological variation, measurement error, expectations and changes in training or diet. A person classified as a nonresponder after one noisy test may not have a stable absence of benefit. Use repeated, relevant observations under comparable conditions and consider starting nutrient status or habitual intake. Genetic mechanisms can be informative without making a commercial genetic test a validated prescription. Individualization should improve a practical decision, not turn uncertain differences into permanent athlete labels.

Supplement safety depends on ingredient, dose, duration, health status and other exposures. Natural origin does not guarantee safety, and absence of a reported adverse event in a small trial does not establish long-term safety. Medication interactions, pregnancy, age and kidney or liver disease can change the decision. Distinguish an event occurring during use from a causally established adverse effect. New or severe symptoms require stopping the suspect exposure and appropriate assessment rather than increasing the dose to overcome poor tolerance.

Combining supplements does not guarantee that their individual effects add together or produce synergy. Shared ingredients can increase total exposure, while interactions may alter tolerance, metabolism or the intended response. Evidence for each ingredient alone is different from evidence for the actual combination. Start with a clearly defined purpose and a simple, reviewable plan. Introduce changes under suitable training conditions, record the exact products and outcomes, and reconsider combinations that complicate sleep, gastrointestinal comfort, cost or anti-doping risk.